Chemo-sensitization of CD133+ cancer stem cell enhances the effect of mesenchymal stem cell expressing TRAIL in non-small cell lung cancer cell lines
Pre-clinical studies have demonstrated the efficacy of mesenchymal stem cells (MSCs) expressing tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) or MSC-TRAIL against several tumors. However, due to the existence of cancer stem cells (CSCs), some tumors, including non-small cell...
Saved in:
| Main Authors: | , , , , |
|---|---|
| 格式: | Article |
| 出版: |
Multidisciplinary Digital Publishing Institute
2021
|
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|